Medical Equipment

A Significant Growth Driver for the Epigenetics Market Is the Precision Medicine Drives Growth Of Epigenetics Market

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Epigenetics Market From 2026 To 2030?

The epigenetics market has witnessed rapid expansion recently. It is projected to increase from $12.74 billion in 2025 to $15.62 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.6%. This historical growth can be linked to factors such as a rise in cancer research, the broadening of academic genomics studies, the availability of sophisticated sequencing tools, an intensified focus on molecular diagnostics, and increased financial support for life sciences research.

The epigenetics market size is anticipated to undergo significant growth in the upcoming years. It is projected to expand to $35.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. This expansion during the forecast period can be primarily ascribed to escalating investments in precision medicine, the increasing acceptance of epigenetic therapeutics, the broadening scope of personalized oncology treatments, the wider application of AI-driven genomic analysis, and strengthening collaborations between pharmaceutical entities and research institutions. Prominent developments for the forecast period include a heightened application of epigenetic biomarkers in oncology, a growing uptake of high-throughput epigenetic analysis tools, an increasing requirement for DNA methylation assays, the expansion of epigenetics-based drug discovery initiatives, and improved integration of bioinformatics platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Key Drivers Are Influencing The Growth Of The Epigenetics Market?

The epigenetics market is anticipated to expand due to a rising emphasis on precision medicine. This medical strategy involves tailoring treatments to individual patient needs by factoring in their genetic makeup, environmental influences, and lifestyle choices. Within epigenetics, precision medicine leverages unique epigenetic profiles and genetic information to develop customized healthcare plans, leading to more effective disease management and patient-specific treatments. An illustration of this trend is seen in data from March 2024 by Novotech, an Australia-based biotechnology firm, which reported that in 2023, 43% of the 217 oncology therapies approved by the FDA were precision oncology treatments, with 78 of these utilizing DNA or NGS-detectable biomarkers. Consequently, the heightened focus on precision medicine is fueling the expansion of the epigenetics market.

Which Segments Are Included In The Analysis Of The Epigenetics Market?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Which Trends Are Impacting The Growth Of The Epigenetics Market?

Leading companies within the epigenetics market are increasingly prioritizing the adoption of artificial intelligence (AI)-driven analytics to achieve a competitive advantage. AI-driven analytics refers to the application of artificial intelligence (AI) technologies to automatically process and interpret substantial data volumes. For example, in July 2023, FOXO Technologies, a US-based company, introduced Bioinformatics Services with the goal of revolutionizing epigenetic data analysis. FOXO’s Bioinformatics Services present a adaptable platform of advanced data solutions specifically designed to meet the unique demands of clients across academia, healthcare, and pharmaceutical research. By leveraging an innovative collection of bioinformatic tools, FOXO aims to enable its clients to enhance the speed and accuracy with which they manage, analyze, and interpret data sets, thereby accelerating discoveries and improving their understanding of complex diseases.

Which Key Industry Participants Are Active In The Epigenetics Market?

Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Read the full epigenetics market report here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Epigenetics Market?

North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Epigenetics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2026, By The Business Research Company

Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Epidural Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-catheter-global-market-report

Anesthesia Circuits And Regional Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-circuits-and-regional-anesthesia-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795